In recent years, there are a few studies that described the expression and clinical relevance of VSTM2L in cancer; the mRNA level of VSTM2L is lower in gastric cancer tissues than in adjacent normal tissues and was downregulated in the H. pylori-positive gastric cancer [16]. The gene discussed is VSTM2L; the disease is cancer.